Westenbrink, B Daan <br/><br/>
Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.  [electronic resource] 

 -  Cardiovascular research  Jul 2010 
 - 30-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1755-3245 
<br/><br/><label>Standard No.: </label>10.1093/cvr/cvq041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Animals, Newborn<br/>Cardiotonic Agents--pharmacology<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cells, Cultured<br/>Darbepoetin alfa<br/>Disease Models, Animal<br/>Endothelial Cells--drug effects<br/>Epoetin Alfa<br/>Erythropoietin--analogs & derivatives<br/>Heart Failure--drug therapy<br/>Humans<br/>Male<br/>Myocytes, Cardiac--drug effects<br/>Neovascularization, Physiologic--drug effects<br/>Paracrine Communication--drug effects<br/>RNA, Messenger--metabolism<br/>Rats<br/>Rats, Inbred F344<br/>Rats, Sprague-Dawley<br/>Recombinant Proteins<br/>Recovery of Function<br/>STAT3 Transcription Factor--metabolism<br/>Stem Cell Transplantation<br/>Stem Cells--drug effects<br/>Time Factors<br/>Transcription, Genetic--drug effects<br/>Up-Regulation<br/>Vascular Endothelial Growth Factor A--genetics<br/>Ventricular Function, Left--drug effects<br/>Ventricular Remodeling--drug effects